Taken together, our study indicated that a weak positive association was visible in the relationship between ADIPOQ +45T>G and MS in the dominant genetic model (OR = 1.30, 95% CI = 1.03–1.65). This evidence concerns the gene ADIPOQ and myeloid sarcoma.